JP2004518767A5 - - Google Patents

Download PDF

Info

Publication number
JP2004518767A5
JP2004518767A5 JP2002581413A JP2002581413A JP2004518767A5 JP 2004518767 A5 JP2004518767 A5 JP 2004518767A5 JP 2002581413 A JP2002581413 A JP 2002581413A JP 2002581413 A JP2002581413 A JP 2002581413A JP 2004518767 A5 JP2004518767 A5 JP 2004518767A5
Authority
JP
Japan
Prior art keywords
alkyl
het
aryl
cycloalkyl
alkanediyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002581413A
Other languages
English (en)
Japanese (ja)
Other versions
JP4530612B2 (ja
JP2004518767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/001788 external-priority patent/WO2002083657A2/en
Publication of JP2004518767A publication Critical patent/JP2004518767A/ja
Publication of JP2004518767A5 publication Critical patent/JP2004518767A5/ja
Application granted granted Critical
Publication of JP4530612B2 publication Critical patent/JP4530612B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002581413A 2001-02-14 2002-02-14 広域スペクトルの2−(置換−アミノ)−ベンゾチアゾールスルホンアミドhivプロテアーゼインヒビター Expired - Fee Related JP4530612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200529 2001-02-14
US28775801P 2001-05-02 2001-05-02
PCT/EP2002/001788 WO2002083657A2 (en) 2001-02-14 2002-02-14 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (3)

Publication Number Publication Date
JP2004518767A JP2004518767A (ja) 2004-06-24
JP2004518767A5 true JP2004518767A5 (enExample) 2005-12-22
JP4530612B2 JP4530612B2 (ja) 2010-08-25

Family

ID=26076833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002581413A Expired - Fee Related JP4530612B2 (ja) 2001-02-14 2002-02-14 広域スペクトルの2−(置換−アミノ)−ベンゾチアゾールスルホンアミドhivプロテアーゼインヒビター

Country Status (30)

Country Link
US (1) US7659404B2 (enExample)
EP (1) EP1370543B1 (enExample)
JP (1) JP4530612B2 (enExample)
KR (1) KR100870184B1 (enExample)
CN (2) CN100369904C (enExample)
AP (1) AP1504A (enExample)
AT (1) ATE343567T1 (enExample)
AU (1) AU2002302363B2 (enExample)
BG (1) BG66301B1 (enExample)
BR (1) BR0207862A (enExample)
CA (1) CA2438304C (enExample)
CY (1) CY1108073T1 (enExample)
CZ (1) CZ304273B6 (enExample)
DE (1) DE60215623T2 (enExample)
DK (1) DK1370543T3 (enExample)
EA (1) EA006096B1 (enExample)
EE (1) EE05385B1 (enExample)
ES (1) ES2275866T3 (enExample)
HR (1) HRP20030735B1 (enExample)
HU (1) HU229224B1 (enExample)
IL (2) IL157171A0 (enExample)
MX (1) MXPA03007236A (enExample)
NO (1) NO326174B1 (enExample)
NZ (1) NZ527391A (enExample)
PL (1) PL213327B1 (enExample)
PT (1) PT1370543E (enExample)
SI (1) SI1370543T1 (enExample)
SK (1) SK287582B6 (enExample)
WO (1) WO2002083657A2 (enExample)
ZA (1) ZA200306086B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01012270A (es) 1999-05-28 2003-06-24 Virco Nv Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos.
AU2002226316B2 (en) 2000-10-20 2008-06-26 Virco Bvba Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
EP1370543B1 (en) 2001-02-14 2006-10-25 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
US7109230B2 (en) 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
CA2490764C (en) 2002-07-01 2011-11-22 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP1520247B1 (en) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
OA12893A (en) * 2002-08-02 2006-10-13 Tibotec Pharm Ltd Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors.
BR0305717A (pt) * 2002-08-02 2004-09-28 Tibotec Pharm Ltd Inibidores da protease do hiv 2-amino-benzotiazol sulfonamida de amplo espectro
WO2005030739A1 (en) * 2003-09-30 2005-04-07 Tibotec Pharmaceuticals Ltd. Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
DE10360835A1 (de) * 2003-12-23 2005-07-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
AU2005244121B2 (en) * 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
AR053845A1 (es) 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
JO3090B1 (ar) * 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
US9024038B2 (en) * 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
ES2571479T3 (es) 2012-04-20 2016-05-25 Gilead Sciences Inc Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
CN116354903B (zh) * 2021-12-28 2025-09-09 南京药石科技股份有限公司 一种6-苯并噻唑磺酰氯的制备方法
WO2024206093A1 (en) * 2023-03-24 2024-10-03 Purdue Research Foundation Hiv-1p rotease inhibitors and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69121436T2 (de) 1990-03-09 1997-01-09 Milliken Res Corp Organische Materialien, die sulfonamidogebundene Poly(oxyalkylen)gruppen tragen und ihre Herstellung
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE122007000045I2 (de) 1992-08-25 2011-07-21 Gd Searle Llc Gd Searle Llc Darunavir oder pharmazeutisch vertragliche Salze, Hydroxyethylaminosulfonamide verwendbar als InhibiEster oder Prodrugs davon. toren retroviraler Proteasen.
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
ES2127938T3 (es) * 1993-08-24 1999-05-01 Searle & Co Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
ES2166786T3 (es) 1993-10-01 2002-05-01 Astrazeneca Ab Procedimiento i.
DE69637380T2 (de) 1995-01-20 2009-09-17 G.D. Searle Llc, Chicago Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
US6140505A (en) * 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6861539B1 (en) * 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
CN1149223C (zh) * 1995-03-10 2004-05-12 G·D·瑟尔公司 杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
US6143788A (en) * 1995-03-10 2000-11-07 G.D. Searle & Co. Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5753660A (en) * 1995-11-15 1998-05-19 G. D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6509038B2 (en) 1996-05-20 2003-01-21 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
CZ295502B6 (cs) 1997-03-26 2005-08-17 Janssen Pharmaceutica N. V. Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
EP1042280A2 (en) 1997-12-24 2000-10-11 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
BR9912169A (pt) * 1998-06-19 2001-04-10 Vertex Pharma Inibidores de sulfonamida de protease de aspartil
PT2336134T (pt) * 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
AR031520A1 (es) * 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
EP1370543B1 (en) 2001-02-14 2006-10-25 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Similar Documents

Publication Publication Date Title
CA2438304A1 (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
US11033600B2 (en) Protease transition state inhibitor prodrugs
CN109476705B (zh) 新型环孢菌素衍生物及其用途
ES2393230T3 (es) Uso farmacéutico de amidas sustituidas
JP4808380B2 (ja) Hivプロテアーゼ阻害剤としてのカルバミン酸エステル
AU2022283816A1 (en) Protease inhibitors as antivirals
RU2601742C2 (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
AR036046A1 (es) Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos
RU2004109815A (ru) Пирролопиримидины в качестве средств ингибирования цистеинпротеаз
PL187747B1 (pl) Zastosowanie sulfonamidowego inhibitora proteazy HIV
JPH02152949A (ja) エイズの治療に有用なhivプロテアーゼ阻害剤
EP2585054A1 (en) Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
JP6454335B2 (ja) カテプシンシステインプロテアーゼ阻害剤
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
JP2008519824A5 (enExample)
ES2341778T3 (es) Aplicacion topica de tiazolilamidas.
CA2442870A1 (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
HU201337B (en) Process for producing dipeptide-glycerides and pharmaceutical compositions containing them
US9309213B2 (en) C-3 substituted bicyclooctane based HIV protease inhibitors
ES2689654T3 (es) Preparación de productos intermedios de cobicistat
US12583820B2 (en) Broad spectrum antivirals against coronavirus
CN114667281B (zh) 具有抗hiv活性的cd4模拟物化合物
US7915237B2 (en) Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate and medicaments therefrom
RU2004111789A (ru) Ретиноидные агонисты
JPH04234869A (ja) 新規なアスコルビン酸誘導体類